Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$504,980
-$149,640 QoQ
Shares Held
3,997
-14.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,367
of 2,266 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Destination Wealth Management holds $169,220,042 across 8 Drug Manufacturers - General names. GILD ranks #7 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
280,450 | $71,225,886 | |
| 2 | LLY |
ELI LILLY & Co
|
56,810 | $68,139,623 | |
| 3 | PFE |
Pfizer Inc
|
976,104 | $23,504,584 | |
| 4 | ABBV |
AbbVie Inc.
|
10,699 | $2,692,296 | |
| 5 | NVO |
Novo Nordisk A S
|
39,942 | $1,914,819 | |
| 6 | MRK |
Merck & Co., Inc.
|
6,119 | $786,291 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
3,997 | $504,980 | |
| 8 | AMGN |
Amgen Inc
|
1,247 | $451,563 |
All Filings in GILD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $504,980 | 3,997 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $654,620 | 4,697 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $380,003 | 3,096 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $387,612 | 3,492 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $367,644 | 3,316 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $358,447 | 3,199 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $361,998 | 3,919 | Shares | Sole | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||